Ingredient · Evidence grade B-
Soy isoflavones & genistein for menopause: evidence, studies and safety
Last updated · 6 studies summarized
B- Short answer: Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials.
Key facts
| Evidence grade | B- B- (modest effect, heterogeneous) |
|---|---|
| Use studied | hot flashes |
| Trials | dozens (Cochrane 2013 phytoestrogens: 43 RCTs; Taku 2012: 17 in MA) |
| Participants | 4,364 (Cochrane, all phytoestrogens); 6,653 (Franco 2016, 62 studies) |
| What reviews conclude | Taku 2012: -20.6% frequency, -26.2% severity vs placebo; Franco JAMA 2016: -0.79 hot flashes/day; Cochrane 2013: no conclusive evidence, possible benefit at >30 mg genistein; NCCIH: effect may be small. |
| The Menopause Society (2023) | Not recommended (Level II) – mixed evidence. |
| Also known as | soy, isoflavones, genistein |
Grades: A strong · B moderate · C limited · D none or negative. How we grade.
Every study we reviewed
Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.
-
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.
The US government-funded HALT study followed 351 women for a year. Black cohosh (160 mg a day), a 10-herb blend, and the blend plus more soy food did no better than a dummy pill for hot flashes, while hormone therapy clearly worked.
- Who
- 351 women aged 45–55
- Dose
- black cohosh 160 mg/day; multibotanical; multibotanical + soy diet; hormone therapy; placebo
- Duration
- 12 months
- Result
- No herbal arm differed from placebo at 3, 6 or 12 months (<1 hot flash/day difference); hormone therapy reduced ~4 symptoms/day vs placebo.
- Funding
- US NIH (NCCAM/NIA) – HALT study, independent. Independent / academic
-
Phytoestrogens for menopausal vasomotor symptoms.
An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.
- Who
- 43 RCTs, 4,364 women
- Dose
- various phytoestrogens
- Duration
- various
- Result
- No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
- Funding
- Cochrane review (independent). Independent / academic
-
Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
Pooling 17 trials, soy isoflavone supplements (about 54 mg a day) cut hot-flash frequency by about a fifth more than placebo. Products higher in genistein worked better. Results varied widely between studies.
- Who
- 17 RCTs in meta-analysis
- Dose
- median 54 mg isoflavones/day
- Duration
- 6 weeks–12 months
- Result
- Hot-flash frequency -20.6% and severity -26.2% vs placebo; >18.8 mg genistein about twice as effective.
- Funding
- Academic (Japan/US); funding not stated in abstract. Funding not stated
-
Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.
A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.
- Who
- 62 studies, 6,653 women
- Dose
- phytoestrogens and other plant therapies
- Duration
- various
- Result
- Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
- Funding
- Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked
-
Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Italian women took high-dose soy isoflavones (150 mg a day) or placebo for 5 years. A small number on soy developed thickening of the womb lining (3.4% vs 0%), so long-term high doses deserve caution.
- Who
- 376 women with intact uterus
- Dose
- soy isoflavones 150 mg/day
- Duration
- 5 years
- Result
- Endometrial hyperplasia in 3.37% on soy vs 0% placebo; no cancers.
- Funding
- Not stated in abstract. Funding not stated
-
Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.
Studies following women with breast cancer found eating soy was linked to lower recurrence, not higher. These looked at soy food, not concentrated supplements.
- Who
- 12 cohort studies, 37,275 breast-cancer patients
- Dose
- dietary soy/isoflavone intake
- Duration
- observational
- Result
- Pre- and post-diagnosis soy intake associated with lower recurrence; no harm signal.
- Funding
- Academic. Independent / academic
Safety
Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH).
Ranked products that contain it
| Product | Amount per day | Score | $/day |
|---|---|---|---|
| Centrum Menopause Support Complete Multivitamin + Hot Flash Support | Genistein: 30 mg | 75.4 | $0.67 |
| The 'Pause Nutrition MenoMulti | Genistein: 54 mg | 69.9 | $1.50 |
| One A Day Women's Menopause Formula | Soybean isoflavones: 60 mg | 65.7 | $0.40 |
| Estroven Menopause Relief + Weight Management | Soy isoflavones: 56 mg | 58.4 | $0.63 |
| Happy V Menopause Relief AM + PM | Genistein from Sophora japonica: 40 mg | 48.9 | $2.00 |
| AZO Menopause Relief Daytime Gummies | Genistein: 30 mg | 48.6 | $0.68 |
FAQ
Does Soy isoflavones & genistein help with menopause symptoms?
Soy isoflavones (including genistein) are the most widely studied supplement group for occasional hot flashes associated with menopause*. Meta-analyses find modest average effects, such as about 20% fewer hot flashes than placebo in one analysis, and results vary between trials. Our evidence grade is B- (modest effect, heterogeneous). Taku 2012: -20.6% frequency, -26.2% severity vs placebo; Franco JAMA 2016: -0.79 hot flashes/day; Cochrane 2013: no conclusive evidence, possible benefit at >30 mg genistein; NCCIH: effect may be small.
Does The Menopause Society recommend Soy isoflavones & genistein?
Not recommended (Level II) – mixed evidence. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.
Is Soy isoflavones & genistein safe?
Soy is a common allergen. In a 5-year trial of 150 mg/day isoflavones, endometrial hyperplasia occurred in 3.4% vs 0% on placebo (Unfer 2004). Cohort studies of soy foods in breast-cancer survivors link them with lower recurrence and show no harm signal, but the safety of concentrated isoflavone supplements after breast cancer is uncertain (NCCIH). Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.
Sources
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.